FALAGARIO, UGO GIOVANNI
 Distribuzione geografica
Continente #
EU - Europa 1.090
NA - Nord America 704
AS - Asia 53
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
Totale 1.853
Nazione #
US - Stati Uniti d'America 701
IE - Irlanda 507
SE - Svezia 273
IT - Italia 133
UA - Ucraina 61
CN - Cina 36
BE - Belgio 22
FR - Francia 21
GB - Regno Unito 19
FI - Finlandia 14
DE - Germania 12
GR - Grecia 10
IR - Iran 8
ES - Italia 4
IN - India 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AT - Austria 3
PL - Polonia 3
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
RU - Federazione Russa 2
CA - Canada 1
JP - Giappone 1
NG - Nigeria 1
NL - Olanda 1
RO - Romania 1
TW - Taiwan 1
VN - Vietnam 1
Totale 1.853
Città #
Dublin 506
Chandler 237
Nyköping 179
Princeton 40
Jacksonville 37
Ashburn 24
Brussels 22
Dearborn 21
Wilmington 18
Rome 17
Helsinki 14
Des Moines 11
Nanjing 10
Milan 9
London 7
Marousi 7
Bari 6
Beijing 6
Naples 6
New York 6
Tehran 6
Foggia 5
Genoa 5
Los Angeles 4
Massa Lombarda 4
Pescara 4
Redwood City 4
Shenyang 4
Villasanta 4
Casalgrande 3
Chengdu 3
Dallas 3
Frankfurt am Main 3
Nanchang 3
Norwalk 3
Paris 3
Suri 3
Valencia 3
Ann Arbor 2
Asiago 2
Athens 2
Atlanta 2
Banja Luka 2
Bethel 2
Bisceglie 2
Bitonto 2
Budapest 2
Cary 2
Cedar Knolls 2
Corleone 2
Coventry 2
Edinburgh 2
Florence 2
Greensboro 2
Hebei 2
Jiaxing 2
Krakow 2
Meriden 2
Monza 2
Nairobi 2
Newcastle upon Tyne 2
Petah Tikva 2
San Diego 2
San Giorgio Ionico 2
San José 2
San Mateo 2
Tianjin 2
Trivento 2
Vienna 2
Washington 2
Woodbridge 2
Ancona 1
Asbest 1
Barletta 1
Barsinghausen 1
Bitetto 1
Boardman 1
Bologna 1
Borås 1
Bresso 1
Cambridge 1
Casamassima 1
Chicago 1
Clearwater 1
Concesio 1
Council Bluffs 1
Duncan 1
Forlì 1
Giovinazzo 1
Gradisca d'Isonzo 1
Grand Junction 1
Gricignano di Aversa 1
Guangzhou 1
Haikou 1
Hanley 1
Hanoi 1
Hanover 1
Houston 1
Kemerovo 1
Kifissia 1
Totale 1.345
Nome #
Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer 121
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study 88
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 75
Elderly patients are not at higher risk of urinary incontinence after radical prostatectomy 75
Elderly patients and prostate biopsy. How old is too old? 72
Defining Prostate Cancer at Favorable Intermediate Risk: the Potential Utility Of Magnetic Resonance Imaging And Genomic Tests 66
The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer 62
Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy 58
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives 55
Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary? 52
Male esthetic genital surgery: recommendations and gaps to be filled 51
Prostatic inflammation is associated with benign prostatic hyperplasia rather than prostate cancer 50
Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study 50
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis 50
Multiparametric magnetic resonance imaging/transrectal ultrasound fusion-guided prostate biopsy: A comparison with systematic transrectal ultrasound-guided prostate biopsy 49
Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer 48
Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators 45
Advanced ureteroscopic techniques for the management of kidney stones 44
One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal Microscopy 44
Prostate cancer biomarkers: a practical review based on different clinical scenarios 42
Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern 41
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 41
Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette–Guerin 40
Preserving ejaculatory function in young patients with lower urinary tract symptoms: medium- to long-term follow-up of prostatic urethral lift at a single center 38
Elderly patients and prostate biopsy. How old is too old? 38
Are Two Meshes Better than One in Sacrocolpopexy for Pelvic Organ Prolapse? Comparison of Single Anterior versus Anterior and Posterior Vaginal Mesh Procedures 37
Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients? 36
Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation Outcomes.  35
Nomogram predicting 30-day mortality after nephrectomy in the contemporary era: Results from the SEER database 34
Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors 33
A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Novel Hormonal Therapies for Non-Metastatic Castration-Resistant Prostate Cancer: An Update From Mature Overall Survival Data 33
Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere? 31
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry 29
Performance of prostate multiparametric Mri for prediction of prostate cancer extra-prostatic extension according to nccn risk categories: implication for surgical planning 29
A Matched-Pair Analysis after Robotic and Retropubic Radical Prostatectomy: A New Definition of Continence and the Impact of Different Surgical Techniques 28
Staging Accuracy of Multiparametric Magnetic Resonance Imaging in Caucasian and African American Men Undergoing Radical Prostatectomy 28
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry 27
Using biomarkers in patients with positive multiparametric magnetic resonance imaging: 4Kscore predicts the presence of cancer outside the index lesion 27
Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies 26
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study 26
Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation 24
Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization 24
Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies 23
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation 21
Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy” 19
Radiomics in prostate cancer: an up-to-date review 16
Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle? 8
Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement 7
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review 6
Oncological outcomes of whole-gland cryoablation in patients with prostate cancer and high risk of lymph node invasion 6
Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification 4
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors 3
External Validation of the IMPROD-MRI Volumetric Model to Predict the Utility of Systematic Biopsies at the Time of Targeted Biopsy 3
Minimally invasive surgical therapies (MISTs) for lower urinary tract symptoms (LUTS): promise or panacea? 3
Totale 2.021
Categoria #
all - tutte 11.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.442


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 6 1 1 0 8
2019/2020129 21 15 23 0 12 17 17 0 9 2 13 0
2020/2021123 8 0 7 0 7 0 16 19 22 28 7 9
2021/2022315 13 13 10 11 33 7 26 11 54 62 6 69
2022/20231.271 111 83 35 61 72 96 8 110 589 34 46 26
2023/2024167 38 36 27 16 29 21 0 0 0 0 0 0
Totale 2.021